Latest & greatest articles for cannabis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cannabis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cannabis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cannabis

61. Medical Cannabis Use in the Elderly: Clinical Effectiveness and Guidelines

Medical Cannabis Use in the Elderly: Clinical Effectiveness and Guidelines Medical Cannabis Use in the Elderly: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis Use in the Elderly: Clinical Effectiveness and Guidelines Medical Cannabis Use in the Elderly: Clinical Effectiveness and Guidelines Published on: December 21, 2017 Project Number: RA0944-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What (...) is the clinical effectiveness on the use of medical cannabis in the elderly? What are the evidence-based guidelines on the use of medical cannabis in the elderly? Key Message One systematic review, four randomized controlled trials, and two non-randomized studies were identified regarding the clinical effectiveness on the use of medical cannabis in the elderly. Tags geriatrics, aged, cannabinoids, cannabis, marijuana abuse, older adult, Elderly Files Rapid Response Reference List Published : December 21, 2017

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

62. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The management of chronic pain is a complex challenge worldwide. Cannabis-based medicines (CBMs) have proven to be efficient in reducing chronic pain, although the topic remains highly controversial in this field.This study's aim is to conduct a conclusive review and meta-analysis, which incorporates all randomized controlled trials (RCTs) in order to update clinicians (...) , cannabinoids have marked effects, so that inadequate blinding of the placebo could constitute an important source of limitation in these types of studies.The current systematic review suggests that CBMs might be effective for chronic pain treatment, based on limited evidence, primarily for neuropathic pain (NP) patients. Additionally, GI AEs occurred more frequently when CBMs were administered via oral/oromucosal routes than by inhalation.Key words: Cannabis, CBMs, chronic pain, postoperative pain, review

2017 EvidenceUpdates

63. Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use

Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use McMaster Health Forum 1 Evidence >> Insight >> Action Supported by the Michael G. DeGroote Initiative for Innovation in Healthcare Rapid Synthesis Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use 31 July 2017 McMaster Health Forum 1 Evidence >> Insight >> Action Rapid Synthesis: Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use 30-day response (...) 20 June 2017 20 JUNE 2017 Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use 2 Evidence >> Insight >> Action McMaster Health Forum and Forum+ The goal of the McMaster Health Forum, and its Forum+ initiative, is to generate action on the pressing health- and social-system issues of our time, based on the best available research evidence and systematically elicited citizen values and stakeholder insights. We aim to strengthen health and social systems – locally

2017 McMaster Health Forum

64. Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines

Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Published (...) on: September 28, 2017 Project Number: RA0934-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of integrated cessation programs in adults who smoke cannabis and tobacco? What are the evidence-based guidelines associated with the use of integrated cessation programs in adults who smoke cannabis and tobacco? Key Message One systematic review with meta-analysis and one randomized controlled trial were identified

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

65. Pharmacological Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines

Pharmacological Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines Pharmacological Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Pharmacological Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines Pharmacological Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness (...) and Guidelines Published on: September 22, 2017 Project Number: RA0933-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the clinical effectiveness of pharmacological interventions for the prevention or treatment of cannabis use in adults? What are the evidence-based guidelines associated with the use of pharmacological interventions for the prevention or treatment of cannabis use in adults? Key Message Four systematic reviews and two randomized controlled

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

66. Psychological and Psychosocial Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines

Psychological and Psychosocial Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines Psychological and Psychosocial Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Psychological and Psychosocial Interventions for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines Psychological and Psychosocial Interventions (...) for the Prevention or Treatment of Cannabis Use: Clinical Effectiveness and Guidelines Published on: September 15, 2017 Project Number: RA0932-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of psychological and psychosocial interventions for the prevention or treatment of cannabis use in adults? What are the evidence-based guidelines associated with the use of psychological and psychosocial interventions

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

67. Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review. (PubMed)

Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review. Cannabis is available from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet its efficacy in treating PTSD symptoms remains uncertain.To identify ongoing studies and review existing evidence regarding the benefits and harms of plant-based cannabis preparations in treating PTSD in adults.MEDLINE, the Cochrane Library, and other sources from (...) database inception to March 2017.English-language systematic reviews, trials, and observational studies with a control group that reported PTSD symptoms and adverse effects of plant-based cannabis use in adults with PTSD.Study data extracted by 1 investigator was checked by a second reviewer; 2 reviewers independently assessed study quality, and the investigator group graded the overall strength of evidence by using standard criteria.Two systematic reviews, 3 observational studies, and no randomized

Full Text available with Trip Pro

2017 Annals of Internal Medicine

68. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. (PubMed)

The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. Cannabis is increasingly available for the treatment of chronic pain, yet its efficacy remains uncertain.To review the benefits of plant-based cannabis preparations for treating chronic pain in adults and the harms of cannabis use in chronic pain and general adult populations.MEDLINE, Cochrane Database of Systematic Reviews, and several other sources from database inception to March (...) 2017.Intervention trials and observational studies, published in English, involving adults using plant-based cannabis preparations that reported pain, quality of life, or adverse effect outcomes.Two investigators independently abstracted study characteristics and assessed study quality, and the investigator group graded the overall strength of evidence using standard criteria.From 27 chronic pain trials, there is low-strength evidence that cannabis alleviates neuropathic pain but insufficient

Full Text available with Trip Pro

2017 Annals of Internal Medicine

69. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations

Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations Cannabis use is common in North America, especially among young people, and is associated with a risk of various acute and chronic adverse health outcomes. Cannabis control regimes are evolving, for example toward a national legalization policy in Canada, with the aim to improve public health, and thus require evidence-based interventions. As cannabis-related health outcomes may be influenced by behaviors (...) that are modifiable by the user, evidence-based Lower-Risk Cannabis Use Guidelines (LRCUG)-akin to similar guidelines in other health fields-offer a valuable, targeted prevention tool to improve public health outcomes.To systematically review, update, and quality-grade evidence on behavioral factors determining adverse health outcomes from cannabis that may be modifiable by the user, and translate this evidence into revised LRCUG as a public health intervention tool based on an expert consensus process.We used

2017 EvidenceUpdates

70. Severity and outcomes of acute alcoholic pancreatitis in cannabis users (PubMed)

Severity and outcomes of acute alcoholic pancreatitis in cannabis users Cannabis is the most commonly and widely used illicit drug in the world and is also the most commonly used drug of abuse in alcohol drinkers. Experimental studies have shown conflicting results of the effects of cannabis on the severity of acute pancreatitis (AP). The purpose of this study is to ascertain the clinical effects of simultaneous alcohol and cannabis use on severity at presentation and outcomes of acute (...) alcoholic pancreatitis (AAP).A retrospective review was conducted on the patients discharged with principle or secondary diagnosis of AP using ICD-9 & ICD-10 codes during the time period from January 2006 to December 2015 at a large community-based hospital in Central Georgia. Patients with alcoholic pancreatitis with cannabis (CB+) and without cannabis (CB-) use were identified and were matched with sex and age.Our study findings showed that a greater percentage of CB+ patients did not have a systemic

Full Text available with Trip Pro

2017 Translational gastroenterology and hepatology

71. Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines

Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical (...) Effectiveness and Guidelines Published on: June 26, 2017 Project Number: RB1113-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? What are the evidence-based guidelines regarding the use of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? Key Message One randomized controlled trial and one non-randomized

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

72. Cannabis and Canada?s children and youth

Cannabis and Canada?s children and youth Cannabis is the most common illicit drug used worldwide and it is used frequently by Canadian teenagers. Cannabis use during adolescence can cause functional and structural changes to the developing brain, leading to damage. Marijuana use in this age group is strongly linked to: cannabis dependence and other substance use disorders; the initiation and maintenance of tobacco smoking; an increased presence of mental illness, including depression, anxiety (...) and psychosis; impaired neurological development and cognitive decline; and diminished school performance and lifetime achievement. Rates of acute medical care and hospitalization for younger children who have ingested cannabis unintentionally are increasing. Ongoing debate concerning cannabis regulation in Canada makes paying close attention to the evidence for its health effects and ensuring that appropriate safeguards are in place, vital public health priorities. Keywords: Adolescents, CUD, CWS

2017 Canadian Paediatric Society

73. Cost of Cannabis Collisions in Canadian Provinces in 2012 [infographic]

Cost of Cannabis Collisions in Canadian Provinces in 2012 [infographic] COST PER INCIDENT © Canadian Centre on Substance Use and Addiction 2017. ® State Farm and related trademarks and logos are registered trademarks owned by State Farm Mutual Automobile Insurance Company, used under licence by Certas Home and Auto Insurance Company and certain of its affiliates. To learn more read the report at a glance PROPERTY DAMAGE ONLY $10,700 68 % $84,600 59 % $8,532,200 61 % INJURIES VICTIMS (...) BY COLLISION TYPE FATALITIES Cost of Cannabis Collisions in Canadian Provinces in 2012 $1.09 BILLION in economic and social costs 7,794 75 4,407 THOSE 34 YEARS OF AGE AND YOUNGER ACCOUNT FOR APPROXIMATELY + + + OF THESE COSTS $658 Million 16–34 YEAR OLDS ACCOUNT FOR THE MAJORITY OF VICTIMS Reference: Wettlaufer, A., Florica, R.O., Asbridge, M., Beirness, D., Brubacher, J., Callaghan, J.R., … Rehm, J. (2017). Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces. Drug

2017 Canadian Centre on Substance Abuse

74. Collisions Attributable to Cannabis: Estimating the Harms and Costs in the Canadian Provinces (Report at a Glance)

Collisions Attributable to Cannabis: Estimating the Harms and Costs in the Canadian Provinces (Report at a Glance) www.ccsa.ca • www.cclt.ca Report at a Glance Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage de substances Page 1 Collisions Attributable to Cannabis: Estimating the Harms and Costs in the Canadian Provinces After alcohol, cannabis is the most widely used psychoactive substance in Canada and cannabinoids are among the most common (...) psychoactive substances found in dead and injured drivers in Canada (Beasley & Beirness, 2011; Brubacher et al., 2016). In 2012, approximately 10% of Canadians aged 15 and older used cannabis and just under half of those reported driving within two hours of using it (Health Canada, 2012). However, there remains a lot that we don’t know about the extent and costs associated with driving under the influence of cannabis (DUIC). As Canada is poised to introduce legislation to regulate cannabis, conversations

2017 Canadian Centre on Substance Abuse

75. Cannabis Use During Pregnancy: Safety

Cannabis Use During Pregnancy: Safety Cannabis Use During Pregnancy: Safety | CADTH.ca Find the information you need Cannabis Use During Pregnancy: Safety Cannabis Use During Pregnancy: Safety Published on: April 26, 2017 Project Number: RB1087-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical evidence regarding the safety of cannabis use during pregnancy? Key Message Two systematic reviews with meta-analyses and nine non (...) -randomized studies were identified regarding the safety of cannabis use (medical or recreational) during pregnancy for pregnant women and their children. Tags cannabinoids, cannabis, marijuana abuse, pregnancy, pregnant women, teratogens, gynecology/obstetrics, Maternal, Gestation, Abnormality, Fetal, marijuana, marihuana Files Rapid Response Summary of Abstracts Published : April 26, 2017 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

76. The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines

The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines | CADTH.ca Find the information you need The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines Published on: April 19, 2017 Project Number: RC0878-000 Product Line: Research Type: Drug Report Type: Summary (...) with Critical Appraisal Result type: Report Question What is the clinical evidence regarding the safety of the use of medical cannabis with other medications? What are the evidence-based guidelines regarding the interaction of the use of medical cannabis with other medications? Key Message Limited data on medical cannabis and drug-drug interactions were obtained from a low quality systematic review. Nabilone may have additive depressant effects with diazepam when taken together with alcohol and codeine

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

77. Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical and Cost-Effectiveness and Guidelines

Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical and Cost-Effectiveness and Guidelines Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical and Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical and Cost-Effectiveness and Guidelines Medical Cannabis in Residential Transition or Addiction Programs: A Review (...) of Clinical and Cost-Effectiveness and Guidelines Published on: April 5, 2017 Project Number: RC0870-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of medical cannabis in adults with addictions being treated in residential transition/addiction programs? What is the cost-effectiveness of medical cannabis in adults with addictions being treated in residential transition/addiction programs? What

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

78. National Research Agenda on the Health Impacts of Non-Medical Cannabis Use

National Research Agenda on the Health Impacts of Non-Medical Cannabis Use www.ccsa.ca • www.cclt.ca Canadian Centre on Substance Abuse •Centre canadien de lutte contre les toxicomanies Page 1 National Research Agenda on the Health Impacts of Non-Medical Cannabis Use The Issue As Canada moves towards regulating cannabis for non-medical use, there is a pressing need for evidence on the health-related effects of non-medical cannabis use to inform policy decisions. Legislative changes (...) and the impact of these changes must be informed by current, high- quality research and must be monitored to avoid negative impacts on the health of Canadians. Because cannabis use, regulations and impacts cross jurisdictional and sectoral boundaries, generating this research requires a collaborative approach. Expert and Stakeholder Meeting Since 2008, CCSA has worked with federal, provincial and municipal partners at the bureaucratic and political levels to provide evidence- informed advice and analysis

2017 Canadian Centre on Substance Abuse

79. Effect of early, brief computerized interventions on risky alcohol and cannabis use among young people

Effect of early, brief computerized interventions on risky alcohol and cannabis use among young people A Campbell Systematic Review 2017:6 Social Welfare Coordinating Group Geir Smedslund, Sabine Wollscheid, Lin Fang, Wendy Nilsen, Asbjørn Steiro and Lillebeth Larun Effects of Early, Computerized Brief Interventions on Risky Alcohol Use and Risky Cannabis Use Among Young People Published: April 2017 Search executed:April 2016The Campbell Library comprises: • Systematic reviews (titles (...) , protocols and reviews) • Policies and Guidelines Series • Methods Series Go to the library to download these resources, at: www.campbellcollaboration.org/library/ Better evidence for a better world Colophon Title Effects of early, computerized brief interventions on risky alcohol use and risky cannabis use among young people Institution The Campbell Collaboration Authors Smedslund, Geir Wollscheid, Sabine Fang, Lin Nilsen, Wendy Steiro, Asbjørn Larun, Lillebeth DOI 10.4073/csr.2017.6 No. of pages 213

2017 Campbell Collaboration

80. The Use of Medical Cannabis with Other Medications: Safety

The Use of Medical Cannabis with Other Medications: Safety The Use of Medical Cannabis with Other Medications: Safety | CADTH.ca Find the information you need The Use of Medical Cannabis with Other Medications: Safety The Use of Medical Cannabis with Other Medications: Safety Published on: February 23, 2017 Project Number: RA0896-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the clinical evidence regarding the safety of the use of medical (...) cannabis with other medications? What are the evidence-based guidelines regarding the interaction of the use of medical cannabis with other medications? Key Message Two systematic reviews and one non-randomized study were identified regarding the safety of the use of medical cannabis with other medications. Tags cannabinoids, cannabis, drug interactions, drug therapy, marijuana smoking, pharmaceutical preparations, marihuana, marijuana, complementary medicine, Therapeutic, Alcohol, illicit substance

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review